Assembly Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Assembly Biosciences

22/03/2023 20:46

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted
loss of 46 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 45 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of 46 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Assembly Biosciences Inc shares had fallen by 7.7% this
quarter.
    * The company reported a quarterly loss of $22.78 million.
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $2.25 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 08:46 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.45          -0.46          Missed
 Sep. 30 2022      -0.47          -0.48          Missed
 Jun. 30 2022      -0.47          -0.51          Missed
 Mar. 31 2022      -0.47          -0.48          Missed